{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:54:49Z","timestamp":1790283289701,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project","award":["Grant No. 2025ZX161"],"award-info":[{"award-number":["Grant No. 2025ZX161"]}]},{"name":"Ningbo Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation","award":["2024L004"],"award-info":[{"award-number":["2024L004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04469-2","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:26:36Z","timestamp":1782973596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic value of the immune-inflammatory indices in osteosarcoma: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Licheng","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"4469_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.24121","volume":"115","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115:1531\u201343. https:\/\/doi.org\/10.1002\/cncr.24121.","journal-title":"Cancer"},{"key":"4469_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","volume":"152","author":"G Ottaviani","year":"2009","unstructured":"Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3\u201313. https:\/\/doi.org\/10.1007\/978-1-4419-0284-9_1.","journal-title":"Cancer Treat Res"},{"key":"4469_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","volume":"23","author":"S Yu","year":"2024","unstructured":"Yu S, Yao X. Advances on immunotherapy for osteosarcoma. Mol Cancer. 2024;23:192. https:\/\/doi.org\/10.1186\/s12943-024-02105-9.","journal-title":"Mol Cancer"},{"key":"4469_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344. https:\/\/doi.org\/10.1038\/nature07205.","journal-title":"Nature"},{"key":"4469_CR5","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.12998\/wjcc.v10.i7.2194","volume":"10","author":"L-P Peng","year":"2022","unstructured":"Peng L-P, Li J, Li X-F. Prognostic value of neutrophil\/lymphocyte, platelet\/lymphocyte, lymphocyte\/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis. World J Clin Cases. 2022;10:2194\u2013205. https:\/\/doi.org\/10.12998\/wjcc.v10.i7.2194.","journal-title":"World J Clin Cases"},{"key":"4469_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.21873\/invivo.12780","volume":"36","author":"M Matsuo","year":"2022","unstructured":"Matsuo M, Yasumatsu R, Masuda M, Toh S, Wakasaki T, Hashimoto K, et al. Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and\/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab Therapy. Vivo. 2022;36:907\u201317. https:\/\/doi.org\/10.21873\/invivo.12780.","journal-title":"Vivo"},{"key":"4469_CR7","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.clgc.2024.102144","volume":"22","author":"A Salari","year":"2024","unstructured":"Salari A, Ghahari M, Bitaraf M, Fard ES, Haddad M, Momeni SA, et al. Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy. Clin Genitourin Cancer. 2024;22:102144. https:\/\/doi.org\/10.1016\/j.clgc.2024.102144.","journal-title":"Clin Genitourin Cancer"},{"key":"4469_CR8","doi-asserted-by":"publisher","first-page":"3456629","DOI":"10.1155\/2021\/3456629","volume":"2021","author":"X Song","year":"2021","unstructured":"Song X, Zhang H, Yin F, Guo P, Yang X, Liu J, et al. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis. Mediators Inflamm. 2021;2021:3456629. https:\/\/doi.org\/10.1155\/2021\/3456629.","journal-title":"Mediators Inflamm"},{"key":"4469_CR9","doi-asserted-by":"publisher","first-page":"18408","DOI":"10.1002\/jcp.28476","volume":"234","author":"X Huang","year":"2019","unstructured":"Huang X, Hu H, Zhang W, Shao Z. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma. J Cell Physiol. 2019;234:18408\u201314. https:\/\/doi.org\/10.1002\/jcp.28476.","journal-title":"J Cell Physiol"},{"key":"4469_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"4469_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/nu11040826","volume":"11","author":"SR Kim","year":"2019","unstructured":"Kim SR, Kim K, Lee SA, Kwon SO, Lee J-K, Keum N, et al. Effect of Red, Processed, and White Meat Consumption on the Risk of Gastric Cancer: An Overall and Dose\u2013Response Meta-Analysis. Nutrients. 2019;11:826. https:\/\/doi.org\/10.3390\/nu11040826.","journal-title":"Nutrients"},{"key":"4469_CR12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1186\/s12885-022-10477-8","volume":"22","author":"X Huang","year":"2022","unstructured":"Huang X, Liu Y, Liang W, Luo K, Qin Y, Li F, et al. A new model of preoperative systemic inflammatory markers predicting overall survival of osteosarcoma: a multicenter retrospective study. BMC Cancer. 2022;22:1370. https:\/\/doi.org\/10.1186\/s12885-022-10477-8.","journal-title":"BMC Cancer"},{"key":"4469_CR13","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.4103\/njcp.njcp_377_24","volume":"27","author":"F Erdogan","year":"2024","unstructured":"Erdogan F, \u00c7inka H, Yurtbay A, Sezgin H, Coskun H, Dabak N. Diagnostic and Prognostic Role of Neutrophil\/Lymphocyte Ratio, Platelet\/Lymphocyte Ratio and Lymphocyte\/Monocyte Ratio in Pediatric Sarcomas. Niger J Clin Pract. 2024;27:1448\u201355. https:\/\/doi.org\/10.4103\/njcp.njcp_377_24.","journal-title":"Niger J Clin Pract"},{"key":"4469_CR14","doi-asserted-by":"publisher","first-page":"923427","DOI":"10.3389\/fsurg.2022.923427","volume":"9","author":"X He","year":"2022","unstructured":"He X, Wang Y, Ye Q, Wang Y, Min L, Luo Y, et al. Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma. Front Surg. 2022;9:923427. https:\/\/doi.org\/10.3389\/fsurg.2022.923427.","journal-title":"Front Surg"},{"key":"4469_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.fob.2015.08.002","volume":"5","author":"T Liu","year":"2015","unstructured":"Liu T, Fang X-C, Ding Z, Sun Z-G, Sun L-M, Wang Y-L. Pre-operative lymphocyte\u2010to\u2010monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma. FEBS Open Bio. 2015;5:682\u20137. https:\/\/doi.org\/10.1016\/j.fob.2015.08.002.","journal-title":"FEBS Open Bio"},{"key":"4469_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12885-022-09223-x","volume":"22","author":"C Ma","year":"2022","unstructured":"Ma C, Li R, Yu R, Guo J, Xu J, Yuan X, et al. Predictive value of preoperative platelet-to-albumin ratio and apolipoprotein B-to-apolipoprotein A1 ratio for osteosarcoma in children and adolescents: a retrospective study of 118 cases. BMC Cancer. 2022;22:113. https:\/\/doi.org\/10.1186\/s12885-022-09223-x.","journal-title":"BMC Cancer"},{"key":"4469_CR17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/jso.26757","volume":"125","author":"C Ma","year":"2022","unstructured":"Ma C, Yu R, Li J, Guo J, Xu J, Wang X, et al. Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients. J Surg Oncol. 2022;125:754\u201365. https:\/\/doi.org\/10.1002\/jso.26757.","journal-title":"J Surg Oncol"},{"key":"4469_CR18","unstructured":"Yang S, Wu C, Wang L, Shan D, Chen B. Pretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients. Int J Clin Exp Pathol. 2020;13:515\u201324.PMID: 32269690; PMCID: PMC7137012."},{"key":"4469_CR19","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.21873\/anticanres.15570","volume":"42","author":"Y Araki","year":"2022","unstructured":"Araki Y, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Igarashi K, et al. Pretreatment Neutrophil Count and Platelet-lymphocyte Ratio as Predictors of Metastasis in Patients With Osteosarcoma. Anticancer Res. 2022;42:1081\u20139. https:\/\/doi.org\/10.21873\/anticanres.15570.","journal-title":"Anticancer Res"},{"key":"4469_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/MPH.0000000000000911","volume":"39","author":"L Vasquez","year":"2017","unstructured":"Vasquez L, Le\u00f3n E, Beltran B, Maza I, Oscanoa M, Geronimo J. Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas. J Pediatr Hematol Oncol. 2017;39:538\u201346. https:\/\/doi.org\/10.1097\/MPH.0000000000000911.","journal-title":"J Pediatr Hematol Oncol"},{"key":"4469_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12957-016-0889-2","volume":"14","author":"W-K Xia","year":"2016","unstructured":"Xia W-K, Liu Z-L, Shen D, Lin Q-F, Su J, Mao W-D. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma. World J Surg Onc. 2016;14:127. https:\/\/doi.org\/10.1186\/s12957-016-0889-2.","journal-title":"World J Surg Onc"},{"key":"4469_CR22","doi-asserted-by":"publisher","first-page":"972352","DOI":"10.3389\/fgene.2022.972352","volume":"13","author":"X He","year":"2022","unstructured":"He X, Tang F, Zou C, Li L, Wang Y, Kenmegne GR, et al. Prognostic significance of modified lung immune prognostic index in osteosarcoma patients. Front Genet. 2022;13:972352. https:\/\/doi.org\/10.3389\/fgene.2022.972352.","journal-title":"Front Genet"},{"key":"4469_CR23","doi-asserted-by":"publisher","first-page":"e31029","DOI":"10.1002\/pbc.31029","volume":"71","author":"P Bastard","year":"2024","unstructured":"Bastard P, Cozic N, Brion R, Gaspar N, Piperno-Neumann S, Cordero C, et al. Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience. Pediatr Blood Cancer. 2024;71:e31029. https:\/\/doi.org\/10.1002\/pbc.31029.","journal-title":"Pediatr Blood Cancer"},{"key":"4469_CR24","doi-asserted-by":"publisher","first-page":"39862","DOI":"10.1038\/srep39862","volume":"6","author":"B Liu","year":"2016","unstructured":"Liu B, Huang Y, Sun Y, Zhang J, Yao Y, Shen Z, et al. Prognostic value of inflammation-based scores in patients with osteosarcoma. Sci Rep. 2016;6:39862. https:\/\/doi.org\/10.1038\/srep39862.","journal-title":"Sci Rep"},{"key":"4469_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12957-020-1789-z","volume":"18","author":"Q Yang","year":"2020","unstructured":"Yang Q, Chen T, Yao Z, Zhang X. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma. World J Surg Onc. 2020;18:24. https:\/\/doi.org\/10.1186\/s12957-020-1789-z.","journal-title":"World J Surg Onc"},{"key":"4469_CR26","doi-asserted-by":"publisher","first-page":"e30382","DOI":"10.1097\/MD.0000000000030382","volume":"101","author":"H Peng","year":"2022","unstructured":"Peng H, Fang X, Xu Y, Wei L, Qin Y, Yang F, et al. Prognostic value of preoperative P-CRP in patients with osteosarcoma: A retrospective study of 101 cases. Medicine. 2022;101:e30382. https:\/\/doi.org\/10.1097\/MD.0000000000030382.","journal-title":"Medicine"},{"key":"4469_CR27","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.2147\/OTT.S140560","volume":"10","author":"Y-J Li","year":"2017","unstructured":"Li Y-J, Yao K, Lu M-X, Zhang W-B, Xiao C, Tu C-Q. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma. OTT. 2017;10:5255\u201361. https:\/\/doi.org\/10.2147\/OTT.S140560.","journal-title":"OTT"},{"key":"4469_CR28","doi-asserted-by":"publisher","first-page":"12673","DOI":"10.2147\/OTT.S287192","volume":"13","author":"H Hu","year":"2020","unstructured":"Hu H, Deng X, Song Q, Lv H, Chen W, Xing X, et al. Prognostic Value of the Preoperative Lymphocyte-to-C-Reactive Protein Ratio and Albumin-to-Globulin Ratio in Patients with Osteosarcoma. OTT. 2020;13:12673\u201381. https:\/\/doi.org\/10.2147\/OTT.S287192.","journal-title":"OTT"},{"key":"4469_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.clon.2019.01.011","volume":"31","author":"N Aggerholm-Pedersen","year":"2019","unstructured":"Pedersen NA, Maretty-Kongstad K, Keller J, Safwat A. Serum Biomarkers as Prognostic Factors for Metastatic Sarcoma. Clin Oncol. 2019;31:242\u20139. https:\/\/doi.org\/10.1016\/j.clon.2019.01.011.","journal-title":"Clin Oncol"},{"key":"4469_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12885-021-09130-7","volume":"22","author":"H Tang","year":"2022","unstructured":"Tang H, Liu D, Lu J, He J, Ji S, Liao S, et al. Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study. BMC Cancer. 2022;22:33. https:\/\/doi.org\/10.1186\/s12885-021-09130-7.","journal-title":"BMC Cancer"},{"key":"4469_CR31","doi-asserted-by":"publisher","first-page":"1235158","DOI":"10.3389\/fonc.2023.1235158","volume":"13","author":"L Li","year":"2023","unstructured":"Li L, Li Y, Lu M, Wang Y, Li Z, Hu X, et al. The combination of baseline neutrophil to lymphocyte ratio and dynamic changes during treatment can better predict the survival of osteosarcoma patients. Front Oncol. 2023;13:1235158. https:\/\/doi.org\/10.3389\/fonc.2023.1235158.","journal-title":"Front Oncol"},{"key":"4469_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tranon.2016.05.006","volume":"9","author":"NA Pedersen","year":"2016","unstructured":"Pedersen NA, Maretty-Kongstad K, Keller J, Baerentzen S, Safwat A. The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma. Translational Oncol. 2016;9:322\u20138. https:\/\/doi.org\/10.1016\/j.tranon.2016.05.006.","journal-title":"Translational Oncol"},{"key":"4469_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u201399. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025.","journal-title":"Cell"},{"key":"4469_CR34","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493\u2013503. https:\/\/doi.org\/10.1016\/S1470-2045(14)70263-3.","journal-title":"Lancet Oncol"},{"key":"4469_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","volume":"500","author":"C Chen","year":"2021","unstructured":"Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 2021;500:1\u201310. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.024.","journal-title":"Cancer Lett"},{"key":"4469_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11914-023-00803-9","volume":"21","author":"I Panez-Toro","year":"2023","unstructured":"Panez-Toro I, Mu\u00f1oz-Garc\u00eda J, Vargas-Franco JW, Renodon-Corni\u00e8re A, Heymann M-F, L\u00e9zot F, et al. Advances in Osteosarcoma. Curr Osteoporos Rep. 2023;21:330\u201343. https:\/\/doi.org\/10.1007\/s11914-023-00803-9.","journal-title":"Curr Osteoporos Rep"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04469-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:03:52Z","timestamp":1790258632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04469-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"380"}}